Cartesian Therapeutics, Inc.
RNAC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$77,424 | -$219,710 | $35,379 | -$25,687 |
| Dep. & Amort. | $1,151 | $843 | $1,287 | $1,252 |
| Deferred Tax | $287 | -$19,000 | -$21,404 | $2,396 |
| Stock-Based Comp. | $6,582 | $22,524 | $11,194 | $7,720 |
| Change in WC | -$5,791 | $4,971 | -$60,377 | -$48,194 |
| Other Non-Cash | $51,521 | $159,211 | $2,290 | $2,131 |
| Operating Cash Flow | -$23,674 | -$51,161 | -$31,631 | -$60,382 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$9,093 | -$206 | -$1,201 | -$1,085 |
| Net Acquisitions | $351 | $6,561 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$33,501 | -$32,455 |
| Inv. Sales/Matur. | $0 | $28,254 | $19,700 | $16,400 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$8,742 | $34,609 | -$15,002 | -$17,140 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$27,457 | $0 | $0 |
| Stock Issued | $124,438 | $0 | $38,980 | $51,958 |
| Stock Repurch. | $0 | -$6,169 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $43,990 | $20,481 | $235 | $939 |
| Financing Cash Flow | $168,428 | -$13,145 | $39,215 | $52,897 |
| Forex Effect | -$21 | -$53 | $20 | -$3 |
| Net Chg. in Cash | $135,991 | -$29,750 | -$7,398 | -$24,628 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $78,288 | $108,038 | $115,436 | $140,064 |
| End Cash | $214,279 | $78,288 | $108,038 | $115,436 |
| Free Cash Flow | -$32,767 | -$51,367 | -$32,832 | -$61,467 |